The in-vitro bleeding time for the screening of platelet function in the newborn: Assessment of a normal reference range [6]

European Journal of Pediatrics

Volumn 160, Issue 3, 2001, Pages 199-200

  Borzini, P ^a   Lazzaro, A ^a   Mazzucco, L ^a   Papili, F ^a  

^a Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; FIBRINOGEN RECEPTOR AFFECTING AGENT; PADGEM PROTEIN; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

BLEEDING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REFERENCE VALUE; THROMBOCYTE FUNCTION;

EID: 0035102046     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008426     Document Type: Letter

References (6)

1. Platelets cryopreserved with thrombosol second messenger inhibitors and low-dose dimethyl sulfoxide are comparable to standard platelet concentrates stored at 22°C
2. The platelet function analyzer (PFA-100): A novel in-vitro system for evaluation of primary haemostasis in children
3. Hyporeactivity of neonate platelets is not caused by preactivation during birth
4. Neonatal platelet physiology and pathophysiology
5. The quality of platelet concentrates: Soluble cytokines and the in-vitro bleeding time
6. Maternal and neonatal primary hemostasis